$FR
FIRST INDUSTRIAL REALTY TRUST INC

2023 Q2 Form 10-Q Financial Statement

#000092182523000028 Filed on April 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $152.2M $149.4M
YoY Change 17.05% 19.05%
Cost Of Revenue $39.76M $42.18M
YoY Change 14.05% 19.11%
Gross Profit $112.5M $107.2M
YoY Change 18.15% 19.03%
Gross Profit Margin 73.88% 71.77%
Selling, General & Admin $9.520M $9.354M
YoY Change 15.41% 7.01%
% of Gross Profit 8.46% 8.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $38.07M $31.65M
YoY Change 13.18% 12.4%
% of Gross Profit 33.85% 29.51%
Operating Expenses $50.11M $49.13M
YoY Change 12.06% 15.18%
Operating Profit $62.36M $58.12M
YoY Change 23.55% 22.48%
Interest Expense -$18.72M $9.827M
YoY Change -117.47% -194.36%
% of Operating Profit -30.01% 16.91%
Other Income/Expense, Net -$5.750M -$17.02M
YoY Change -46.79% 63.81%
Pretax Income $56.69M $40.31M
YoY Change 42.94% 8.78%
Income Tax $459.0K $7.167M
% Of Pretax Income 0.81% 17.78%
Net Earnings $54.58M $55.97M
YoY Change -53.34% 54.36%
Net Earnings / Revenue 35.86% 37.46%
Basic Earnings Per Share $0.41 $0.42
Diluted Earnings Per Share $0.41 $0.42
COMMON SHARES
Basic Shares Outstanding 132.2M shares 132.2M shares
Diluted Shares Outstanding 132.3M shares 132.3M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.10M $65.83M
YoY Change -49.64% 48.09%
Cash & Equivalents $68.10M $65.84M
Short-Term Investments
Other Short-Term Assets $224.9M $228.1M
YoY Change 22.11% 29.57%
Inventory $72.00K
Prepaid Expenses
Receivables $6.643M $9.190M
Other Receivables $133.9M $128.4M
Total Short-Term Assets $433.7M $431.5M
YoY Change 0.13% 30.86%
LONG-TERM ASSETS
Property, Plant & Equipment $4.618B $4.480B
YoY Change 10.03% 12.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.37M $33.94M
YoY Change 344.14% -9.18%
Other Assets $0.00 $5.864M
YoY Change 3002.65%
Total Long-Term Assets $4.656B $4.519B
YoY Change 10.06% 11.61%
TOTAL ASSETS
Total Short-Term Assets $433.7M $431.5M
Total Long-Term Assets $4.656B $4.519B
Total Assets $5.089B $4.951B
YoY Change 9.14% 13.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $174.6M $174.2M
YoY Change -16.87% 2.47%
Accrued Expenses $22.20M $22.00M
YoY Change -0.36% -1.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $241.1M $240.3M
YoY Change -11.58% 3.3%
LONG-TERM LIABILITIES
Long-Term Debt $2.182B $2.081B
YoY Change 14.45% 17.85%
Other Long-Term Liabilities $104.2M $101.8M
YoY Change -7.11% -5.93%
Total Long-Term Liabilities $2.286B $2.183B
YoY Change 13.25% 16.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $241.1M $240.3M
Total Long-Term Liabilities $2.286B $2.183B
Total Liabilities $2.598B $2.423B
YoY Change 13.38% 15.02%
SHAREHOLDERS EQUITY
Retained Earnings $48.22M $35.99M
YoY Change
Common Stock $1.323M $1.322M
YoY Change 0.15% 0.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.491B $2.458B
YoY Change
Total Liabilities & Shareholders Equity $5.089B $4.951B
YoY Change 9.14% 13.06%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $54.58M $55.97M
YoY Change -53.34% 54.36%
Depreciation, Depletion And Amortization $38.07M $31.65M
YoY Change 13.18% 12.4%
Cash From Operating Activities $85.79M $70.32M
YoY Change -56.89% 17.4%
INVESTING ACTIVITIES
Capital Expenditures $161.8M $99.90M
YoY Change -169.01% -150.18%
Acquisitions
YoY Change
Other Investing Activities $14.81M $1.260M
YoY Change -49.87% -51.16%
Cash From Investing Activities -$147.0M -$104.1M
YoY Change -28.27% -48.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 57.59M -$39.61M
YoY Change -40.32% -130.71%
NET CHANGE
Cash From Operating Activities 85.79M $70.32M
Cash From Investing Activities -147.0M -$104.1M
Cash From Financing Activities 57.59M -$39.61M
Net Change In Cash -3.601M -$73.42M
YoY Change -103.98% 419.41%
FREE CASH FLOW
Cash From Operating Activities $85.79M $70.32M
Capital Expenditures $161.8M $99.90M
Free Cash Flow -$76.00M -$29.58M
YoY Change -117.53% -111.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Trading Symbol
TradingSymbol
FR
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
FIRST INDUSTRIAL REALTY TRUST, INC.
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000921825
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132243163 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132241965 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132141503 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132241965 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132241965 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132141503 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132141503 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.320
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.295
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13102
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
FIRST INDUSTRIAL REALTY TRUST, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-3935116
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One North Wacker Drive, Suite 4200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60606
CY2023Q1 dei City Area Code
CityAreaCode
312
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
344-4300
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
FR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132243163 shares
CY2023Q1 us-gaap Land
Land
1648867000 usd
CY2022Q4 us-gaap Land
Land
1646179000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3487413000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3442957000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
265720000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
253903000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
946767000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
921480000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4455233000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4421559000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24283000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24580000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65835000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
133244000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5864000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11874000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
9190000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
7135000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
33943000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
8822000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
128442000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
122918000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
228062000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
224190000 usd
CY2023Q1 us-gaap Assets
Assets
4950852000 usd
CY2022Q4 us-gaap Assets
Assets
4954322000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
10220000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
10299000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
993922000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
993742000 usd
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
919662000 usd
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
919260000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
157000000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
143000000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
174222000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
194031000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21995000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
22266000 usd
CY2023Q1 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
101805000 usd
CY2022Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
100166000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
44061000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
41259000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2422887000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2424023000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132241965 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132241965 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132141503 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132141503 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1322000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1321000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2400269000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2401334000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35987000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23131000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20732000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
33412000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2458310000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2459198000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
69655000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
71101000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2527965000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2530299000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4950852000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4954322000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
146606000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
124912000 usd
CY2023Q1 fr Joint Venture Fees
JointVentureFees
1073000 usd
CY2022Q1 fr Joint Venture Fees
JointVentureFees
37000 usd
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
1744000 usd
CY2022Q1 us-gaap Other Operating Income
OtherOperatingIncome
564000 usd
CY2023Q1 us-gaap Revenues
Revenues
149423000 usd
CY2022Q1 us-gaap Revenues
Revenues
125513000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
42182000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
35415000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9354000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8741000 usd
CY2023Q1 fr Joint Venture Development Services Expense
JointVentureDevelopmentServicesExpense
784000 usd
CY2022Q1 fr Joint Venture Development Services Expense
JointVentureDevelopmentServicesExpense
0 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39772000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33910000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
92092000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
78066000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16119000 usd
CY2022Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9636000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
904000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
756000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17023000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10392000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40308000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37055000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27634000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-22000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7167000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
37123000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4808000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
865000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55967000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
36258000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132211000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131811000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132299000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131885000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
37123000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-13020000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
11095000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-102000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-102000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47857000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
48320000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4482000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1127000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43375000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47193000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2530299000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
130728 shares
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12918000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4627000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.320
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
43460000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11358000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2527965000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2248372000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
37123000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11197000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12746000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2721000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.295
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
39887000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
103000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2272375000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
37123000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
31650000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
28159000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
904000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
756000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7502000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
8330000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27634000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-22000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5208000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2023Q1 fr Straight Line Rent Adjustment Net
StraightLineRentAdjustmentNet
5498000 usd
CY2022Q1 fr Straight Line Rent Adjustment Net
StraightLineRentAdjustmentNet
4247000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
12357000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
8692000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
9768000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-1553000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70318000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59898000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
5559000 usd
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
83391000 usd
CY2023Q1 us-gaap Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
94336000 usd
CY2022Q1 us-gaap Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
115666000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2973000 usd
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1383000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1260000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2580000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104128000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-203020000 usd
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
CY2022Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
7000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12823000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2459000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2942000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39713000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
36206000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
79000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
784000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
80000000 usd
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
168000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
66000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
12000000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
103000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
11358000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39609000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128987000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-73419000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14135000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145118000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58780000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71699000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44645000 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
3981000 usd
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
4069000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
861000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
807000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
56000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
44061000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
40298000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2023Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1000 usd
CY2022Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
151000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
60410000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
105390000 usd
CY2023Q1 fr Tenant Improvements Funded By Tenant
TenantImprovementsFundedByTenant
2528000 usd
CY2022Q1 fr Tenant Improvements Funded By Tenant
TenantImprovementsFundedByTenant
0 usd
CY2023Q1 fr Write Off Of Fully Depreciated Assets
WriteOffOfFullyDepreciatedAssets
10331000 usd
CY2022Q1 fr Write Off Of Fully Depreciated Assets
WriteOffOfFullyDepreciatedAssets
5428000 usd
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
431 property
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
18 state
CY2023Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
65700000 sqft
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
431 property
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to conform with GAAP, in preparation of our consolidated financial statements we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of March 31, 2023 and December 31, 2022, and the reported amounts of revenues and expenses for the three months ended March 31, 2023 and 2022. Actual results could differ from those estimates. In our opinion, the accompanying unaudited interim consolidated financial statements reflect all adjustments necessary for a fair statement of our financial position as of March 31, 2023 and December 31, 2022, the results of our operations and comprehensive income for each of the three months ended March 31, 2023 and 2022, and our cash flows for each of the three months ended March 31, 2023 and 2022. All adjustments are of a normal recurring nature.</span></div>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred Leasing Intangibles, Net as of December 31, 2022 have been reclassified to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid Expenses and Other Assets, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line item and to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Payable, Accrued Expenses and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line item in the consolidated balance sheets to conform to the 2023 presentation. Joint Venture Fees for the three months ended March 31, 2022 has been reclassified from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line item in the consolidated statements of operations to conform to the 2023 presentation.</span></div>
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
241000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
335000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
457349000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
200364000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
556449000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
876053000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2090791000 usd
CY2023Q1 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
9710000 usd
CY2022Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
9765000 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
897208000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
883444000 usd
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
910113000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
909187000 usd
CY2023Q1 us-gaap Lines Of Credit Fair Value Disclosure
LinesOfCreditFairValueDisclosure
157000000 usd
CY2022Q4 us-gaap Lines Of Credit Fair Value Disclosure
LinesOfCreditFairValueDisclosure
143000000 usd
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1974031000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1945396000 usd
CY2023Q1 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
410000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55967000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
36258000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
47000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
31000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55920000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36227000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132211000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131811000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
74000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132299000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131885000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125185 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6141000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5101000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1706000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1173000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19581000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y14D
CY2023Q1 fr Receivable Due From Affiliates
ReceivableDueFromAffiliates
9285000 usd
CY2022Q4 fr Receivable Due From Affiliates
ReceivableDueFromAffiliates
9285000 usd

Files In Submission

Name View Source Status
0000921825-23-000028-index-headers.html Edgar Link pending
0000921825-23-000028-index.html Edgar Link pending
0000921825-23-000028.txt Edgar Link pending
0000921825-23-000028-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fr-20230331.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fr-20230331.xsd Edgar Link pending
fr-20230331_g1.jpg Edgar Link pending
fr-2023331xex311.htm Edgar Link pending
fr-2023331xex312.htm Edgar Link pending
fr-2023331xex313.htm Edgar Link pending
fr-2023331xex314.htm Edgar Link pending
fr-2023331xex321.htm Edgar Link pending
fr-2023331xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
fr-20230331_def.xml Edgar Link unprocessable
fr-20230331_lab.xml Edgar Link unprocessable
fr-20230331_pre.xml Edgar Link unprocessable
fr-20230331_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fr-20230331_cal.xml Edgar Link unprocessable